| scholarly article | Q13442814 |
| review article | Q7318358 |
| P6179 | Dimensions Publication ID | 1023911153 |
| P356 | DOI | 10.1007/S11906-003-0084-Z |
| P8608 | Fatcat ID | release_xyuxakk6fbcxjeha3mhd7rc4ce |
| P698 | PubMed publication ID | 12948431 |
| P50 | author | Alexandre A da Silva | Q57036828 |
| P2093 | author name string | Jiankang Liu | |
| John E Hall | |||
| Jay J Kuo | |||
| Daniel W Jones | |||
| Lakshmi S Tallam | |||
| P2860 | cites work | The Prospective Cardiovascular Münster (PROCAM) study: prevalence of hyperlipidemia in persons with hypertension and/or diabetes mellitus and the relationship to coronary heart disease | Q67987025 |
| Incidence and precursors of hypertension in young adults: the Framingham Offspring Study | Q69038435 | ||
| Renal denervation attenuates the sodium retention and hypertension associated with obesity | Q72166811 | ||
| Adrenergic and reflex abnormalities in obesity-related hypertension | Q73098364 | ||
| Influence of obesity on the appearance of proteinuria and renal insufficiency after unilateral nephrectomy | Q73108248 | ||
| Antihypertensive and Lipid-Lowering Treatment to Prevent Heart Attack Trial (ALLHAT): practical implications | Q73270201 | ||
| Inhibition of NO synthesis enhances chronic cardiovascular and renal actions of leptin | Q73567403 | ||
| Leptin acts in the central nervous system to produce dose-dependent changes in arterial pressure | Q73598793 | ||
| Functional and structural changes in the kidney in the early stages of obesity | Q73928010 | ||
| Blood pressure is associated with body mass index in both normal and obese children | Q74188082 | ||
| What can we do about the "epidemic" of obesity | Q74464572 | ||
| Overweight and sympathetic overactivity in black Americans | Q74537816 | ||
| Sympathetic neural activation in visceral obesity | Q78503922 | ||
| Prevalence and Trends in Obesity Among US Adults, 1999-2000 | Q22253005 | ||
| Obesity Hypertension in Children: A Problem of Epidemic Proportions | Q22306387 | ||
| Cardiovascular disease risk factors among older black, Mexican-American, and white women and men: an analysis of NHANES III, 1988-1994. Third National Health and Nutrition Examination Survey | Q32028174 | ||
| Oxidative stress in a rat model of obesity-induced hypertension. | Q32071927 | ||
| The puzzle of hypertension in African-Americans. | Q33369000 | ||
| Calorie restriction in obesity: prevention of kidney disease in rodents | Q34174781 | ||
| Obesity-associated hypertension and kidney disease | Q34177580 | ||
| The kidney, hypertension, and obesity | Q34182175 | ||
| Obesity-related glomerulopathy: an emerging epidemic | Q34190647 | ||
| Choice of drug treatment for obesity-related hypertension: where is the evidence? | Q34237354 | ||
| Obesity hypertension: role of leptin and sympathetic nervous system | Q34285448 | ||
| Sympathetic nervous system and insulin resistance: from obesity to diabetes | Q34448148 | ||
| Leptin signaling, adiposity, and energy balance | Q34524449 | ||
| Mechanisms of obesity-associated cardiovascular and renal disease | Q34870994 | ||
| Contrasting blood pressure effects of obesity in leptin-deficient ob/ob mice and agouti yellow obese mice | Q38314767 | ||
| Human leptin deficiency caused by a missense mutation: multiple endocrine defects, decreased sympathetic tone, and immune system dysfunction indicate new targets for leptin action, greater central than peripheral resistance to the effects of leptin, | Q38319405 | ||
| Long-term effects of weight loss and dietary sodium reduction on incidence of hypertension | Q39061314 | ||
| Prevalence and trends in overweight among US children and adolescents, 1999-2000 | Q39513388 | ||
| Pathophysiological role of leptin in obesity-related hypertension. | Q40437354 | ||
| Lisinopril versus hydrochlorothiazide in obese hypertensive patients: a multicenter placebo-controlled trial. Treatment in Obese Patients With Hypertension (TROPHY) Study Group | Q42548538 | ||
| Antihypertensive effect of alpha- and beta-adrenergic blockade in obese and lean hypertensive subjects | Q43683199 | ||
| Treatment of obesity hypertension and diabetes syndrome | Q43744789 | ||
| Participation of the hypothalamus-hypophysis axis in the sympathetic activation of human obesity | Q43829666 | ||
| Chronic cardiovascular and renal actions of leptin: role of adrenergic activity | Q43908233 | ||
| Angiotensin blockade prevents type 2 diabetes by formation of fat cells | Q44201653 | ||
| Results of the Diet, Exercise, and Weight Loss Intervention Trial (DEW-IT). | Q44201657 | ||
| Beneficial effects of weight loss in overweight patients with chronic proteinuric nephropathies | Q44293250 | ||
| Interactions between leptin and the human sympathetic nervous system | Q44385728 | ||
| Weight change and duration of overweight and obesity in the incidence of type 2 diabetes. | Q47257907 | ||
| Interactions between the melanocortin system and leptin in control of sympathetic nerve traffic | Q48292251 | ||
| Hypothalamic melanocortin receptors and chronic regulation of arterial pressure and renal function. | Q48371185 | ||
| Chronic leptin infusion increases arterial pressure | Q48547443 | ||
| Ethnic differences in insulinemia and sympathetic tone as links between obesity and blood pressure. | Q51553099 | ||
| Overweight and obesity as determinants of cardiovascular risk: the Framingham experience. | Q54656315 | ||
| P433 | issue | 5 | |
| P921 | main subject | obesity | Q12174 |
| arterial hypertension | Q41861 | ||
| epidemic | Q44512 | ||
| P304 | page(s) | 386-392 | |
| P577 | publication date | 2003-10-01 | |
| P1433 | published in | Current Hypertension Reports | Q15746362 |
| P1476 | title | Impact of the obesity epidemic on hypertension and renal disease. | |
| P478 | volume | 5 |
| Q50624165 | A genome-wide scan of loci linked to serum adiponectin in two populations of African descent. |
| Q37551661 | AT2 receptor non-peptide agonist C21 promotes natriuresis in obese Zucker rats. |
| Q37298368 | Adipocyte-derived factor reduces vasodilatory capability in ob-/ob- mice |
| Q35749652 | Angiotensin AT2 receptor agonist prevents salt-sensitive hypertension in obese Zucker rats |
| Q28383911 | Anti-mullerian hormone as a predictor of time to menopause in late reproductive age women |
| Q36970053 | Association of adiposity status and changes in early to mid-adulthood with incidence of Alzheimer's disease |
| Q33653083 | Body size affects measures of ovarian reserve in late reproductive age women |
| Q34515571 | Central obesity and albuminuria: both cross-sectional and longitudinal studies in Chinese |
| Q33881270 | Chronic AT2 receptor activation increases renal ACE2 activity, attenuates AT1 receptor function and blood pressure in obese Zucker rats |
| Q38580775 | Effects of probiotics consumption on lowering lipids and CVD risk factors: a systematic review and meta-analysis of randomized controlled trials. |
| Q50146272 | Evaluation of lipid profiles and hematological parameters in hypertensive patients: Laboratory-based cross-sectional study. |
| Q47375496 | Glucose variability for cardiovascular risk factors in type 2 diabetes: a meta-analysis. |
| Q47264301 | Kinetic analysis of cardiac transcriptome regulation during chronic high-fat diet in dogs. |
| Q45304577 | Leptin receptors are expressed in coronary arteries, and hyperleptinemia causes significant coronary endothelial dysfunction |
| Q33584896 | Leptinemia and its association with stroke and coronary heart disease in the Jackson Heart Study |
| Q34635250 | Metabolic syndrome, chronic kidney, and cardiovascular diseases: role of adipokines. |
| Q38204543 | Metabolic syndrome: a sympathetic disease? |
| Q41634709 | Non-invasive blood pressure measurement: values, problems and applicability in the common marmoset (Callithrix jacchus). |
| Q36632429 | Nonpharmacologic therapy for hypertension: does it really work? |
| Q22241459 | Obesity and Risk for Chronic Renal Failure |
| Q22242405 | Obesity and central obesity as risk factors for incident dementia and its subtypes: a systematic review and meta-analysis |
| Q36515043 | Obesity and diabetic kidney disease |
| Q34311562 | Obesity and hypertension: two epidemics or one? |
| Q37601245 | Obesity, hypertension, and chronic kidney disease |
| Q35224446 | Obesity, metabolic syndrome and diabetic nephropathy |
| Q37781054 | Orlistat and calcium oxalate crystalluria: an association that needs consideration |
| Q48508863 | Phenotypic characteristics associated with hypertension in patients with obstructive sleep apnea |
| Q85006861 | Prevalence of overweight and obesity in adults in an urban health area |
| Q34215745 | Progression is accelerated from prehypertension to hypertension in blacks |
| Q33773316 | Relationship between anthropometric measures and cardiovascular risk factors in children and adolescents. |
| Q36765690 | Renal denervation abolishes the age-dependent increase in blood pressure in female intrauterine growth-restricted rats at 12 months of age |
| Q48100821 | Synergistical action of the β2 adrenoceptor and fatty acid binding protein 2 polymorphisms on the loss of glomerular filtration rate in Chinese patients with type 2 diabetic nephropathy |
| Q26771261 | The Intricate Network of Adipokines and Stroke |
| Q36485238 | The complex role of PPARgamma in renal dysfunction in obesity: managing a Janus-faced receptor |
| Q35021492 | The pathophysiology of hypertension in patients with obesity |
| Q37874892 | The role of angiotensin receptor blockers in diabetic nephropathy |
| Q37719241 | The role of sympathetic nervous activity in renal injury and end-stage renal disease. |
| Q33622500 | The role of the sympathetic nervous system in obesity-related hypertension |
Search more.